^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    AGAR T cells

    i
    Associations
    News

    Trials

    Company:
    Baylor College of Medicine
    Drug class:
    IL-15R stimulant, GPC-3-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News

    Trials

    Apply
    Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors (NCT05103631)
    Phase 1
    Baylor College of Medicine
    Recruiting
    Last update posted :
    08/23/2023
    Initiation :
    06/17/2021
    Primary completion :
    01/01/2025
    Completion :
    12/01/2039
    GPC3
    |
    GPC3 positive
    |
    cyclophosphamide • fludarabine IV • AGAR T cells • cyclophosphamide intravenous
    Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04377932)
    Phase 1
    Baylor College of Medicine
    Recruiting
    Last update posted :
    07/07/2023
    Initiation :
    12/08/2021
    Primary completion :
    02/01/2025
    Completion :
    02/01/2040
    GPC3
    |
    GPC3 positive
    |
    cyclophosphamide • fludarabine IV • AGAR T cells • GLYCAR T cells • cyclophosphamide intravenous